Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
---|
02/02/2012 | WO2011109732A3 Reverse thermal gels and uses therefor |
02/02/2012 | WO2011106788A3 Car peptide for homing, diagnosis, & targeted therapy for pulmonary and fibrotic disorders |
02/02/2012 | WO2011106684A3 Compositions and methods for modulating autophagy |
02/02/2012 | WO2011100428A3 Compositions for improving bone mass |
02/02/2012 | WO2011081465A9 Pharmaceutical composition for suppression of vascularization |
02/02/2012 | WO2011079073A3 Herpes simplex virus vaccines |
02/02/2012 | WO2011036443A9 S1 protease c- terminal polypeptides and uses thereof for treating inflammation or coagulation disorders |
02/02/2012 | US20120030838 Novel fungal enzymes |
02/02/2012 | US20120030779 Compositions and methods for detecting, treating, or preventing reductive stress |
02/02/2012 | US20120029168 Method for ameliorating pain by modification of nmda receptors through inhibition of src |
02/02/2012 | US20120029061 Rna sequence-specific mediators of rna interference |
02/02/2012 | US20120029049 Antisense Modulation of Superoxide Dismutase 1, Soluble Expression |
02/02/2012 | US20120028944 Cyclodextrin nanotechnology for ophthalmic drug delivery |
02/02/2012 | US20120028913 Peptides for inhibiting chemokine binding to chemokine receptors |
02/02/2012 | US20120028912 Methods of modulating bromodomains |
02/02/2012 | US20120028911 Mucin Derived Polypeptides |
02/02/2012 | US20120028910 Storage-stable aqueous ophthalmic formulations |
02/02/2012 | US20120028909 FN14/TRAIL Fusion Proteins |
02/02/2012 | US20120028908 Methods of Manufacturing Crystalline Forms of Rapamycin Analogs |
02/02/2012 | US20120028907 Methods for identification of tumor phenotype and treatment |
02/02/2012 | US20120028906 Method for affecting the timing of cervical ripening and for parturition |
02/02/2012 | US20120028905 Isolation, Purification, and Structure Elucidation of the Antiproliferative Compound Coibamide A |
02/02/2012 | US20120028904 Methods, systems, and compositions for calpain inhabition |
02/02/2012 | US20120028903 Modulation of the activity and differentiation of cells expressing the osteoclast-associated receptor |
02/02/2012 | US20120028902 Peptide availability |
02/02/2012 | US20120028901 Tfpi inhibitors and methods of use |
02/02/2012 | US20120028900 Method of producing factor viii proteins by recombinant methods |
02/02/2012 | US20120028899 Composition and process for synthesizing tense and relaxed state polymerized hemoglobin |
02/02/2012 | US20120028898 Methods for treatment of headaches by administration of oxytocin |
02/02/2012 | US20120028897 Methods and compositions for the treatment of fluid retention disorders |
02/02/2012 | US20120028896 Use of fibroblast growth factor fragments |
02/02/2012 | US20120028895 Inhibiting Serum Response Factor (SRF) to Improve Glycemic Control |
02/02/2012 | US20120028894 Peptides, pharmaceutical compositions comprising same and uses thereof |
02/02/2012 | US20120028893 Adenovirus 36 E4 ORF 1 Gene and Protein and Their Uses |
02/02/2012 | US20120028892 Inhibitors of fructose 1,6-bisphosphatase and methods of use thereof |
02/02/2012 | US20120028891 Methods of promoting or maintaining an anabolic state in a female animal |
02/02/2012 | US20120028890 Acid containing lipid formulations |
02/02/2012 | US20120028889 Integrase cofactor |
02/02/2012 | US20120028888 Apj receptor compounds |
02/02/2012 | US20120028887 Lipopeptide inhibitors of hiv-1 |
02/02/2012 | US20120028883 Complex and production process |
02/02/2012 | US20120028882 Method for removing endotoxin from proteins |
02/02/2012 | US20120028881 Methods and reagents for diagnosing atheroma |
02/02/2012 | US20120028880 Vegfr-1/nrp-1 targeting peptides |
02/02/2012 | US20120028879 Highly sensitive detection method for highly virulent oral cavity bacteria |
02/02/2012 | US20120028878 Membrane Evaporation for Generating Highly Concentrated Protein Therapeutics |
02/02/2012 | US20120028877 Self-Buffering Protein Formulations |
02/02/2012 | US20120028300 Whitefly Ecdysone Receptor Nucleic Acids, Polypeptides, and Uses Thereof |
02/02/2012 | US20120028262 Genes and polypeptides relating to human pancreatic cancers |
02/02/2012 | US20120027879 Buccal, polar and non-polar spray or capsule containing drugs for treating metabolic disorders |
02/02/2012 | US20120027872 Apparatus for sealing a puncture by causing a reduction in the circumference of the puncture |
02/02/2012 | US20120027858 Methods and Compositions for Managing Cancer Cell Growth |
02/02/2012 | US20120027850 Compositions and Methods for Treatment of Aortic Fibrosis |
02/02/2012 | US20120027848 Enzyme Delivery Systems and Methods of Preparation and Use |
02/02/2012 | US20120027846 Anti-viral azide containing compounds |
02/02/2012 | US20120027845 Adenovirus AD36 E4 ORF1 Protein For Prevention and Treatment of Non-Alcoholic Fatty Liver Disease |
02/02/2012 | US20120027843 Hb-egf bound protein complex |
02/02/2012 | US20120027842 Topical formulations of flap inhibitors for administration to an eye |
02/02/2012 | US20120027835 Surgical prosthesis having biodegradable and nonbiodegradable regions |
02/02/2012 | US20120027832 Use of edds and calcium ions as enhancers of molluscicidal activity |
02/02/2012 | US20120027815 Use of plasma membrane calcium atpase (pmca) inhibitors to inhibit sperm mobility |
02/02/2012 | US20120027814 Polymeric Fibers Having Tissue Reactive Members |
02/02/2012 | US20120027808 Nicotine immunonanotherapeutics |
02/02/2012 | US20120027805 Controlled-Released Peptide Formulations |
02/02/2012 | US20120027801 Polypeptides from neisseria meningitidis |
02/02/2012 | US20120027792 Expression vectors able to elicit improved immune response and methods of using same |
02/02/2012 | US20120027791 Antisense compound for inducing immunological tolerance |
02/02/2012 | US20120027790 Immunological herpes simplex virus antigens and methods for use thereof |
02/02/2012 | US20120027785 Chimera comprising bacterial cytotoxin and methods of using the same |
02/02/2012 | US20120027784 Monomethylvaline compounds capable of conjugation to ligands |
02/02/2012 | US20120027783 Monomethylvaline compounds capable of conjugation to ligands |
02/02/2012 | US20120027778 Frizzled-Binding Agents and Uses Thereof |
02/02/2012 | US20120027776 Diabetic model |
02/02/2012 | US20120027770 Novel cell and therapeutical and diagnostical methods based thereon |
02/02/2012 | US20120027766 Methods and means for treatment of osteoarthritis |
02/02/2012 | US20120027764 Novel polypeptide, cdna encoding the same, and use thereof |
02/02/2012 | US20120027759 Methods of enhancing t cell responsiveness |
02/02/2012 | US20120027755 Prevention and treatment of alzheimer's disease |
02/02/2012 | US20120027751 Antagonists of tweak and of tweak receptor and their use to treat immunological disorders |
02/02/2012 | US20120027746 Method for generating thrombin |
02/02/2012 | US20120027745 Alanine-glyoxylate aminotransferase therapeutics |
02/02/2012 | US20120027744 Modified heparinase iii and methods of sequencing therewith |
02/02/2012 | US20120027743 Method for the Treatment of Hemophilia |
02/02/2012 | US20120027742 Methods for treating adult respiratory distress syndrome |
02/02/2012 | US20120027740 Method and means for producing tissues and tissues obtained |
02/02/2012 | US20120027735 Symbiotic maple product compositions and methods |
02/02/2012 | US20120027732 Thermoreversible collagen |
02/02/2012 | US20120027726 Methods for Distributing High Levels of Therapeutic Agent Throughout the Cortex to Treat Neurological Disorders |
02/02/2012 | US20120027723 Taurine or taurine-like substances for the prevention and treatment of a disease associated with retinal ganglion cell degeneration |
02/02/2012 | US20120027722 Hepatitis c virus combination therapy |
02/02/2012 | US20120027721 HCV Inhibitor and Therapeutic Agent Combinations |
02/02/2012 | US20120027720 Peptide conjugates |
02/02/2012 | US20120027706 Methods for treating skin pigmentation |
02/02/2012 | US20120027705 Administration of cells and cellular extracts for rejuvenation |
02/02/2012 | US20120027703 Novel proteasome-activating anti-aging peptides and compositions containing same |
02/02/2012 | US20120027694 Inducible release vehicles |
02/02/2012 | US20120027690 Ph-sensitive graft copolymer, manufacturing method for same, and polymer micelles using method |
02/02/2012 | US20120027687 Fatty acid protein kinase c activators and anticoagulant for the treatment of stroke |
02/02/2012 | US20120027684 Cancer therapy based on tumor associated antigens derived from cyclin d1 |
02/02/2012 | US20120027683 Diabetes t cell receptors |